Fibrosis Unknown Status Phase 2 Trials for Ribavirin (DB00811)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00148837Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe FibrosisTreatment